# NSN 6505-00-869-4177: Oxymetazoline Hydrochloride Nasa

NSN 6505-00-869-4177 (also written 6505008694177; NIIN 00-869-4177) is an oxymetazoline hydrochloride nasa in Federal Supply Class 6505, Drugs and Biologicals. 3 manufacturer part numbers from 2 suppliers are on record. It was last purchased in Oct 2026.

## Identification

- NSN: 6505-00-869-4177 (6505008694177)
- NIIN: 00-869-4177 (008694177)
- Item name: OXYMETAZOLINE HYDROCHLORIDE NASA
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC 0 (observed 2026-10-10)
- Acquisition method code: 0

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CSGS | ADMINISTRATION | NASAL |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | PERCENTAGE, W/V OXYMETAZOLINE HYDROCHLORIDE ACTIVE INGREDIENT 0.050 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION 15ML SPRAY BT |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 15.000 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE, SQUEEZE SPRAY |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| AFRIN | 4WBU5 | BAYER HEALTHCARE LLC DBA ANIMAL HEALTH DIVISION DIV ANIMAL HEALTH | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC00904-7435-35 | 1LEZ0 | THE HARVARD DRUG GROUP, L.L.C. DBA FIRST VETERINARY SUPPLY DIV MAJOR PHARMACEUTICALS & RUGBY LABORATORIES | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC11523-1167-06 | 4WBU5 | BAYER HEALTHCARE LLC DBA ANIMAL HEALTH DIVISION DIV ANIMAL HEALTH | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-10-12 | [SPE2DX25D9822/SPE2D227F0020](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $15.00 |
| 2026-10-08 | [SPE2DX25D9900/SPE2DP27F0134](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.55 |
| 2026-10-01 | [SPE2DX25D9900/SPE2DP27F0025](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $15.10 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F025K](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.55 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F026C](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $3.02 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F027B](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.55 |
| 2026-09-29 | [SPE2DX25D9900/SPE2DP26F027H](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.55 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F023H](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $9.06 |
| 2026-09-28 | [SPE2DX25D9900/SPE2DP26F024D](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $6.04 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F015D](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.55 |
| 2026-09-24 | [SPE2DX25D9900/SPE2DP26F009G](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $6.04 |
| 2026-09-22 | [SPE2DX25D9822/SPE2D226F3549](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $7.50 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F006B](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177) | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI | DMS PHARMACEUTICAL GROUP INC | $15.10 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505008694177&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505008694177
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-00-869-4177/
JSON: https://nsnexplorer.com/api/nsn/6505-00-869-4177.json